In Silico Characterization of a Novel Bioactive Compound derived from Psidium guajava 4-[5-(Pyridin-4-yl)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-amine: A Potential Inhibitor for Targeting Signaling Proteins involved in Diabetes Development. Int. J. Pharm. Sci. Drug Res. [Internet]. 2024 Mar. 30 [cited 2024 May 18];16(2):180-9. Available from: https://www.ijpsdr.com/index.php/journal/article/view/8584